Cardiff Oncology Cash Conversion Cycle 2011-2026 | CRDF

Annual Cash Conversion Cycle Cardiff Oncology

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000
294	284	396	617	435	-	-	-244	-111	-142	-489	-17.6 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
617	-17.6 K	-1.66 K

Quarterly Cash Conversion Cycle Cardiff Oncology

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	297	351	493	-	296	236	152	-	116	354	795	-	319	224	605	-	373	353	450	-	1.82 K	1.82 K	663	-	346	266	262	-	-2.1 K	126	328	38	182	-154	-59.5	135	-140	-163	-245	114	-390	-1 K	-407	92.4	90.4	93	55.8	153	165	147	94.8	94.3	72.7	370	357	-	164	113	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.82 K	-2.1 K	179

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	3.11 K	-	5743.5 %	$ 69.7 M	Canada
Happiness Biotech Group Limited HAPP	-3.12 K	-	1.35 %	$ 17.8 M	China
Dynavax Technologies Corporation DVAX	459	-	-	$ 2.02 B	USA
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	-101	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Alpine Immune Sciences ALPN	1.73	-	-	$ 2.17 B	USA
AstraZeneca PLC AZN	-58	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
CRISPR Therapeutics AG CRSP	1.1 K	$ 51.54	3.49 %	$ 4.63 B	Schweiz
Affimed N.V. AFMD	31.4	-	-34.95 %	$ 21.5 M	Germany
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Celyad Oncology SA CYAD	-55.7 K	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	214	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	-3.74 K	$ 31.18	-0.3 %	$ 2.07 B	USA
Generation Bio Co. GBIO	47.6	-	-	$ 344 M	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	-1.6 K	-	-4.36 %	$ 27 M	USA
Anika Therapeutics ANIK	192	$ 14.75	0.17 %	$ 212 M	USA
Advaxis ADXS	-82.3 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
Applied Genetic Technologies Corporation AGTC	126	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA
Esperion Therapeutics ESPR	99.7	$ 3.16	0.21 %	$ 657 M	USA
Enlivex Therapeutics Ltd. ENLV	-981	$ 0.69	2.3 %	$ 31.5 M	Israel
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Eton Pharmaceuticals ETON	115	$ 31.57	-0.08 %	$ 849 M	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA